retatrutide dosing for weight loss Extreme Side Effects Followed Overdose of Unapproved Weight-Loss Drug Retatrutide Dosing Guide: 2mg–12mg Protocol

E., Leoncini, R., Casnici, C., et al

Tolerance to GLP-1 medications is not dose-frequency dependent

Comorbidities diabetes, heart disease, or fatty liver disease may influence drug choice

Cardiovascular and Other Safety Considerations Cardiovascular safety monitoring in Phase 2 trials showed heart rate increases of approximately 2-4 beats per minute on average, similar to what has been observed with other GLP-1 agonists

Compared with placebo, retatrutide led to 10 percentage points more weight loss with 4 mg, 16 points with 8 mg, and 17 points with 12 mg

The GLP-1 receptor lowers hunger and slows down food leaving the stomach